Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
26.80
+0.02 (0.07%)
At close: Aug 27, 2025, 4:00 PM
26.80
0.00 (0.00%)
After-hours: Aug 27, 2025, 4:15 PM EDT
CANC Holdings Information
CANC is an equity ETF with a total of 52 individual holdings. The top holdings are Revolution Medicines stock at 5.28%, BridgeBio Pharma at 5.14%, Roche Holding AG at 4.88%, Novartis AG at 4.55%, and Merus at 4.44%.
Total Holdings
52
Top 10 Percentage
42.85%
Asset Class
Equity
ETF Category
Health
Assets
70.76M
PE Ratio
20.39
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | RVMD | Revolution Medicines, Inc. | 5.28% |
| 2 | BBIO | BridgeBio Pharma, Inc. | 5.14% |
| 3 | RHHBY | Roche Holding AG | 4.88% |
| 4 | SWX: NOVN | Novartis AG | 4.55% |
| 5 | MRUS | Merus N.V. | 4.44% |
| 6 | LON: AZN | AstraZeneca PLC | 4.38% |
| 7 | GMAB | Genmab A/S | 4.12% |
| 8 | LLY | Eli Lilly and Company | 3.85% |
| 9 | ONC | BeOne Medicines Ltd. | 3.11% |
| 10 | NUVL | Nuvalent, Inc. | 3.10% |
| 11 | ACLX | Arcellx, Inc. | 3.10% |
| 12 | SMMT | Summit Therapeutics Inc. | 3.07% |
| 13 | BMY | Bristol-Myers Squibb Company | 3.06% |
| 14 | EXEL | Exelixis, Inc. | 3.05% |
| 15 | ZLAB | Zai Lab Limited | 2.90% |
| 16 | ABBV | AbbVie Inc. | 2.87% |
| 17 | LEGN | Legend Biotech Corporation | 2.59% |
| 18 | AMGN | Amgen Inc. | 2.27% |
| 19 | MRK | Merck & Co., Inc. | 2.27% |
| 20 | IDYA | IDEAYA Biosciences, Inc. | 2.25% |
| 21 | GILD | Gilead Sciences, Inc. | 1.94% |
| 22 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80% |
| 23 | ARGX | argenx SE | 1.79% |
| 24 | CELC | Celcuity Inc. | 1.54% |
| 25 | IMNM | Immunome, Inc. | 1.53% |
As of Aug 22, 2025